[4] EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE DOSE OF SIMVASTATIN IN HIGH CARDIOVASCULAR RISK PATIENTS NOT AT LDL-C TARGET WITH SIMVASTATIN ALONE: THE DIALOGUE STUDY

✍ Scribed by M. Averna; A. Zaninelli; C. Le Grazie; G.F. Gensini

• Book ID: 117638939
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 109 KB
• Volume: 19
• Category: Article
• ISSN: 0939-4753
• DOI: 10.1016/s0939-4753(09)70005-5